These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS, Aslam M, Naveed AK, Razi MS. Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671 [Abstract] [Full Text] [Related]
12. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [Abstract] [Full Text] [Related]
15. Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study. Parhofer KG, Otto C, Geiss HC, Laubach E, Göke B. Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):49-52. PubMed ID: 15662596 [Abstract] [Full Text] [Related]
16. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]
20. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes. Betteridge DJ, Vergès B. Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]